Business partnerships with impact
Join us in a strategic partnership to help deliver vital services and support for more than 150,000 Australians living with blood cancer.
We can create a tailored partnership that aligns with your objectives, generates brand awareness, improves employee engagement, grows customer advocacy and delivers social value for the community.
Your environmental and social governance (ESG) strategy is more important than ever before. Consumers, shareholders and employees are demanding companies change the way they do business and use ESG strategies to improve sustainability and transparency.
Research reveals that 67% of Australians see corporates as having as much responsibility for solving society’s problems, as government. And an even higher percentage 76% believe that companies should step in and help charities amid the cost-of-living crisis.
Remarkable Partnerships
Need help?
Environmental and social governance strategies
Let’s work together to achieve your ESG goals and build on a shared purpose to support people with blood cancer.
The Leukaemia Foundation is one of Australia’s most reputable charities* and the next decade has to include big, bold actions to improve treatments, support and outcomes for people with blood cancer. In close collaboration with our valued partners, we’ll continue advocating for greater disease awareness and systemic change in health systems across the country
*Source: 2023 Australian Charity RepTrack Report
Partner with us
Together we can realise a future where no life is lost to blood cancer.
The Leukaemia Foundation funds innovative research and provides wraparound care and support for people with blood cancer across Australia. We encourage our business partners to align investments with their preferred areas of interest including:
What your partnership will support
Practical services
Reduce the burden and stress of a diagnosis by providing people with blood cancer and their families with accommodation, transport, financial assistance and access to our supportive healthcare professionals.
Getting started
How to get involved
Working together, we can transform care for people with blood cancer.
Partnerships can be designed to align with the unique needs and interests of your business.
Sponsor a key fundraising campaign or offer goods and services with in-kind support.
Sponsorships
Encourage employees to donate directly through payroll.
Workplace giving
committed to improving research, services and care for people with blood cancer.
Meet our current partners
Improve employee engagement through fundraising activities.
Fundraising
Together we can make Project 2035 a reality
Supported by leading businesses, Project 2035 is a bold and ambitious project committed to reducing preventable blood cancer deaths to zero by 2035. By becoming part of Project 2035, you will drive innovation forward, revolutionise patient support and shape the direction of leading-edge research.
Blood cancers A-Z
We’re here for anyone with any blood cancer, every step of the way.
A
Acute lymphoblastic leukaemia (ALL)
Acute myeloid leukaemia (AML)
Acute promyelocytic leukaemia (APML)
Adult T-cell lymphoma
AL amyloidosis
Amyloidosis
Anaplastic large cell lymphoma
Aplastic anaemia
B
Biphenotypic leukaemia
Burkitt’s lymphoma
C
Childhood acute lymphoblastic leukaemia (ALL)
Childhood acute myeloid leukaemia (AML)
Childhood blood cancers
Childhood lymphoma
Childhood MDS and MPN
Chronic lymphocytic leukaemia (CLL)
Chronic myeloid leukaemia (CML)
Chronic myelomonocytic leukaemia (CMML)
Cutaneous lymphomas
D
E
Essential thrombocythaemia (ET)
F
H
Hairy cell leukaemia (HCL)
Hodgkin lymphoma (HL)
J
Juvenile myelomonocytic leukaemia (JMML)
L
M
Mucosa-associated lymphoid tissue lymphoma (MALT)
Mantle cell lymphoma (MCL)
Marginal zone lymphoma (MZL)
Monoclonal gammopathy of unknown significance (MGUS)
Myelodysplastic neoplasms (MDS)
Myeloma
Myeloproliferative neoplasms (MPN)
N
P
Peripheral T-cell lymphoma
Polycythaemia (rubra) vera
Primary central nervous system lymphoma
Primary myelofibrosis
S
Skin (cutaneous) lymphomas
Small lymphocytic lymphoma (SLL)